Public Health Interventions and SARS Spread, 2003
Public Health Interventions and SARS Spread, 2003
      The 2003 outbreak of severe acute respiratory syn-        persons with fever at international borders and in public
drome (SARS) was contained largely through traditional          places. After the outbreaks, WHO sought information to
public health interventions, such as finding and isolating      help assess the effectiveness of interventions in preventing
case-patients, quarantining close contacts, and enhanced        the transmission of SARS in the community and interna-
infection control. The independent effectiveness of meas-
                                                                tionally. Of particular interest was information on the
ures to “increase social distance” and wearing masks in
public places requires further evaluation. Limited data exist   effectiveness of thermal scanning of travelers.
on the effectiveness of providing health information to trav-
elers. Entry screening of travelers through health declara-     Methods
tions or thermal scanning at international borders had little      Information was obtained by reviewing scientific liter-
documented effect on detecting SARS cases; exit screen-         ature and surveying members of an informal WHO work-
ing appeared slightly more effective. The value of border       ing group about preventing community and international
screening in deterring travel by ill persons and in building    transmission of SARS. Members were surveyed with stan-
public confidence remains unquantified. Interventions to        dardized questionnaires regarding measures taken in their
control global epidemics should be based on expert advice
                                                                countries and evaluation studies known to them.
from the World Health Organization and national authori-
ties. In the case of SARS, interventions at a country’s bor-
                                                                 1The members of the World Health Organization (WHO) Working
ders should not detract from efforts to identify and isolate
                                                                 Group are as follows: Ximena Aguilera, Ministerio de Salud,
infected persons within the country, monitor or quarantine
                                                                 Santiago Chile; Roy Anderson, Imperial College London, United
their contacts, and strengthen infection control in health-
                                                                 Kingdom; Dounia Bitar, Institut de Veille Sanitaire, Paris France;
care settings.                                                   Martin Cetron (with Pattie Simone), Centers for Disease Control
                                                                 and Prevention, Atlanta, Georgia, USA; Chew Suok Kai (with
                                                                 Benjamin K.W. Koh), Ministry of Health, Singapore; Clete
     he 2003 outbreak of severe acute respiratory syndrome
T    (SARS) is a modern example of containing a global
epidemic through traditional or nonmedical public health
                                                                 DiGiovanni, Jr., Defense Threat Reduction Agency, Fort Belvoir,
                                                                 Virginia, USA; Arlene King, Health Canada, Ottawa, Canada; Cindy
                                                                 K-L Lai (with P.L. Ma), Department of Health, Hong Kong Special
interventions. The interventions included finding and iso-       Administrative Region, China; Angus Nicoll (with Jane Leese),
lating case-patients; quarantining contacts; measures to         Communicable Disease Surveillance Centre, London, United
                                                                 Kingdom; Sonja Olsen, International Emerging Infections Program,
“increase social distance,” such as canceling mass gather-       Nonthaburi, Thailand; Alice Sarradet, Direction Generale de la
ings and closing schools; recommending that the public           Sante, Paris, France; Mingchang Song, General Administration of
augment personal hygiene and wear masks; and limiting            Quality Supervision, Inspection and Quarantine, (AQSIQ), Beijing,
the spread of infection by domestic and international trav-      China; Ron St. John (with Susan Courage), Health Canada,
elers, by issuing travel advisories and screening travelers      Ottawa, Canada; Robert Steffen (with Leonie Prasad), University of
                                                                 Zurich, Switzerland; Ih-Jen Su (with S.K. Lai), Taiwan Center for
at borders. Some measures were implemented pursuant to           Disease Control, Taipei, Taiwan, China; WHO Staff in the
recommendations of the World Health Organization                 Department of Communicable Diseases Surveillance and
(WHO); others were implemented by governments on                 Response (CSR): Julie Hall, Beijing, China; Emmanuel
their own initiative. A novel technology, infrared scanning,     Jesuthasan, Angela Merianos, Cathy Roth, Max Hardiman,
was used extensively in some countries to try to identify        Geneva, Switzerland; Hitoshi Oshitani, Western Pacific Regional
                                                                 Office, Manila, Philippines; and group facilitator: David Bell, WHO
                                                                 (CSR) Geneva, Switzerland, and Centers for Disease Control and
*World Health Organization, Geneva, Switzerland                  Prevention, Atlanta, Georgia, USA.
1900                    Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 11, November 2004
                                                                                       Public Health Interventions and SARS
Results
                        Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 11, November 2004                      1901
POLICY REVIEW
healthcare workers continued to work without recognizing       tires, and pedestrian walking zones. Little information
that they were ill, perhaps confusing their symptoms with      exists on the effectiveness of disinfectant use in reducing
fatigue, despite daily screening and repeated messages not     community or hospital transmission. In Hong Kong, disin-
to come to work if ill. This resulted in transmission to       fecting living quarters thoroughly (not otherwise defined
patients and staff” (B. Henry, Toronto Public Health, pers.    and reported retrospectively by telephone) appeared to be
comm.).                                                        protective (16).
1902                   Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 11, November 2004
                                                                                     Public Health Interventions and SARS
were detected at airports (S. Warintrawat, Ministry of         Taiwan), and Singapore indicate that no cases of SARS
Public Health, Thailand, communication to WHO).                were detected among >7 million people who underwent
                                                               thermal scanning at exit (Table 3) (S. Courage, Health
   Entry Screening                                             Canada, S.K. Lai, China-Taiwan Center for Disease
   Preliminary data from a worldwide survey indicate that      Control; P.L. Ma, Hong Kong SAR China Dept of Health;
among 72 patients with imported probable or confirmed          and B.K.W. Koh, Singapore Ministry of Health, communi-
SARS cases, 30 (42%) had onset of symptoms before or on        cations to WHO). In some areas, “stop lists” were used at
the same day as entry into the country and symptoms            borders to prevent persons on isolation or quarantine lists
developed in 42 patients (58%) after entry (J. Jones,          from exiting. Anecdotes suggest that exit screening may
United Kingdom Health Protection Agency, communica-            have helped dissuade ill persons from traveling by air but
tion to WHO). SARS was diagnosed in a small percentage         may have been more successful in dissuading local resi-
of persons who completed entry health declaration ques-        dents from traveling abroad than in dissuading ill travelers
tionnaires in affected areas during the SARS epidemic.         from attempting to return home.
(Table 1).
   Results combined from Canada, China (including the              Transmission on Commercial Aircraft
mainland and Hong Kong SAR), and Singapore indicate                Five commercial international flights were associated
that no cases of SARS were detected by thermal scanning        with transmission of SARS from patients with sympto-
among >35 million international travelers scanned at entry     matic probable cases to passengers and crew (1).
during the SARS epidemic (Table 2; data for China-Hong         Notification of exposed passengers and studies of transmis-
Kong SAR include travelers arriving from China-main-           sion risk were greatly hampered by difficulties in identify-
land). Temperature screening of 13,839,500 travelers           ing and tracing passenger contacts (19–23). In the most
entering or leaving Beijing by air, train, or automobile       comprehensive investigation, involving three flights with
identified 5,097 patients with fever, of whom 12 had prob-     extensive passenger tracing and laboratory confirmation of
able SARS. These 12 included 10 of 952,200 domestic air-       index and secondary cases, a wide range of risk was noted
line passengers and 2 of 5,246,100 train passengers. None      (Table 4). For flight 2, in which the secondary attack rate
of 275,600 international travelers who underwent temper-       was 18.3%, the risk of infection was increased for persons
ature screening had SARS (5).                                  seated close to the index patient, but most passengers who
   In China-Taiwan, incoming travelers from affected           became infected were seated farther away, even though
areas were quarantined; probable or suspected SARS was         their individual risk was lower (19). In another study, one
diagnosed in 21 (0.03%) of 80,813. None of these 21 was        person with SARS, who had difficulty breathing but was
detected by thermal scanning when they entered China-          not coughing, infected two other passengers. One of these
Taiwan (9) (S.K. Lai, China-Taiwan Center for Disease          sat in the row in front of the index patient but the other pas-
Control, pers. comm.).                                         senger sat four rows, plus a passageway, behind and on the
                                                               opposite side of the plane (20). On nine flights arriving in
   Exit Screening                                              Singapore, the incidence of transmission from passengers
   After WHO recommended exit screening on March 27,           with SARS who had respiratory symptoms was estimated
2003 (18), no additional cases from airline travel were        at 1 in 156 persons (21). A fourth study found no transmis-
documented from countries with screening. Combined             sion to passengers seated near a patient who took multiple
data from China (Hong Kong SAR and Taiwan) indicate            flights (22). In comparison, an influenzalike illness devel-
that among 1.8 million people who completed health ques-       oped within 3 days in 72% of passengers in a plane contain-
tionnaires at exit, 1 probable case of SARS was detected.      ing a person with symptomatic influenza and grounded for
Combined data from Canada, China (Hong Kong SAR and            3 hours without ventilation (24). The risk for transmission
                       Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 11, November 2004                   1903
POLICY REVIEW
of tuberculosis during a long flight was also increased        the most cost-effective ways to accomplish this are uncer-
among, but not limited to, passengers seated close to a        tain. The difficulties in identifying and tracing passengers
highly infectious index patient (25).                          exposed on aircraft highlight the need for public health
                                                               authorities to have a mechanism for rapid access to passen-
Discussion                                                     ger contact information. In the case of SARS, the data on
    SARS-CoV was contained in human populations in             border screening indicate that if resources are limited,
2003 largely by aggressive use of traditional public health    interventions at a country’s international borders should
interventions (case finding and isolation, quarantine of       not detract from efforts to identify and isolate infected per-
close contacts, and enhanced infection control measures in     sons within the country, monitor and quarantine their close
settings where care was provided to persons with SARS,         contacts appropriately, and strengthen infection control in
especially in healthcare facilities and homes). These meas-    healthcare settings.
ures also contained a smaller SARS outbreak in 2004 that           In retrospect, although SARS-CoV was transmitted pri-
originated from a laboratory-acquired infection (26).          marily through the respiratory droplet route, certain epi-
Measures to decrease the interval between onset of symp-       demiologic parameters facilitated its containment through
toms and isolation were effective in containing communi-       public health interventions . Presymptomatic transmission
ty transmission. The independent effectiveness of general      was not observed. Infectivity in most patients was low at
community measures to increase social distance (in addi-       onset of illness and seemed to peak during week 2 of ill-
tion to contact tracing and quarantine) and improve            ness in association with maximal respiratory symptoms,
hygiene and wearing masks in public places requires fur-       when patients were often in the hospital. Virus transmis-
ther evaluation.                                               sion was primarily by respiratory droplets, with little natu-
    Limited information exists on the relative effectiveness   ral airborne dissemination but some environmental spread.
of methods of providing information on SARS (or other          With some important exceptions (Hotel M and Amoy
illnesses) to travelers. For inbound travelers who may have    Gardens in Hong Kong), transmission occurred primarily
been exposed to SARS, such information should include          in healthcare or household settings, with close person-to-
what to do if symptoms develop and the need to inform          person contact. Cases among children were uncommon,
healthcare workers who provide care for them in advance        and children did not seem to be involved in transmission.
to take appropriate precautions. Entry screening of travel-    Although the reproductive number for SARS (R0, the aver-
ers by using health declarations or thermal scanning at        age number of new cases resulting from a single infection
international borders had little documented impact in          in a susceptible community) was approximately 2–4, con-
detecting SARS cases. Exit screening appeared only             tact tracing was facilitated by its relatively long serial
slightly more effective; however, the possible value of        interval (time between onset of symptoms in successive
these interventions in deterring travel by ill persons and     patients in a chain of transmission: mean 8–10 days) and
building public and business confidence was not assessed.      incubation period (median 4–5 days). Most infections did
Preventing passengers with SARS from boarding aircraft         not lead to further transmission, although a small number
would likely have reduced transmission of infection, but       of “super-spreading” events occurred in which single
1904                   Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 11, November 2004
                                                                                          Public Health Interventions and SARS
                                                                 References
                                                                  1. World Health Organization. Consensus document on the epidemiolo-
                                                                     gy of severe acute respiratory syndrome (SARS) WHO/CDS/
                                                                     CSR/GAR/2003. [monograph on the Internet] 2003 Oct 11, 17 [cited
                                                                     2004 Sep 20]. Available from http://www.who.int/csr/sars/en/
                                                                     WHOconsensus.pdf
unrecognized cases transmitted to many people, usually in         2. WHO Global Conference on Severe Acute Respiratory Syndrome
hospitals or households, before appropriate infection con-           (SARS). 17–18 June 2003. [cited 2004 Sep 20]. Available from
trol precautions were in place (1).                                  http://www.who.int/csr/sars/conference/june_2003/en/
    Traditional public health interventions will likely be        3. Riley S, Fraser C, Donnelly CA, Ghani AC, Abu-Raddad LJ, Hedley
                                                                     AJ, et al. Transmission dynamics of the etiological agent of SARS in
required again to combat an emerging or reemerging infec-            Hong Kong: impact of public health interventions. Science.
tion for which specific antimicrobial drug therapy and vac-          2003;300:1961–6.
cines are nonexistent or in short supply. For infections that     4. Lipsitch M, Cohen C, Cooper B, Robins JM, Ma S, James L, et al.
are relatively less transmissible (e. g., SARS or a strain of        Transmission dynamics and control of severe acute respiratory syn-
                                                                     drome. Science. 2003;300:1966–70.
avian influenza not fully adapted to human-to-human trans-        5. Pang X, Zhu Z, Xu F, Guo J, Gong X, Liu D, et al. Evaluation of con-
mission), early and bold use of such interventions may con-          trol measures implemented in the severe acute respiratory syndrome
tain transmission. For more readily transmissible infections         outbreak in Beijing, 2003. JAMA. 2003;290:3215–21.
(e.g., an emerging pandemic strain of influenza), they            6. Svoboda T, Henry B, Shulman L, Kennedy E, Rea E, Ng W, et al.
                                                                     Public health measures to control the spread of the severe acute res-
would not completely halt transmission but might “buy                piratory syndrome in Toronto. N Engl J Med. 2004;350:2352–61.
time” during a narrow window of opportunity during which          7. Gostin LO, Bayer R, Fairchild AL. Ethical and legal implications
an effective vaccine could be produced and other prepara-            posed by the severe acute respiratory syndrome: implications for the
tions made. For countries lacking specific countermeasures,          control of severe infectious disease threats. JAMA.
                                                                     2003;290:3229–37.
such as drugs and vaccines, nonmedical public health inter-       8. Cetron M, Maloney S, Koppaka R, Simone P. Isolation and quaran-
ventions may be the only measures available to combat epi-           tine: containment strategies for SARS 2003. In: Knobler S, Mahmoud
demics (27). Decisions regarding implementation should be            M, Lemon S, Mack A, Sivitz L, Oberholtzer K, editors. Learning
based on expert scientific advice from WHO and national              from SARS: preparing for the next disease outbreak. Forum on
                                                                     microbial threats, board of health. Institute of Medicine of the
authorities; the epidemiologic features of the disease and           National Academies. Washington: National Academies Press; 2004.
available resources should be taken into account. This arti-         p. 71–83.
cle does not address political and economic factors that may      9. Lee ML, Chen CJ, Su IJ, Chen KT, Yeh CC, King CC, et al. Use of
lead to calls for adopting certain measures or the economic          quarantine to prevent transmission of severe acute respiratory syn-
                                                                     drome- Taiwan, 2003. MMWR Morb Mortal Wkly Rep.
and social consequences that may ensue, but governments              2003;52:680–3.
will also consider such factors in their decisions.              10. Lai CKL. Hong Kong Department of Health. Presentation at
    The WHO SARS Scientific Research Advisory                        Symposium on Rethinking Quarantines: New Considerations for
Committee has identified further research needs for SARS             “Old Medicine.” Center for Strategic and International Studies.
                                                                     Washington, D.C. Sep17, 2003.
(28). Priorities include evaluating the effectiveness of pub-    11. Ou J, Li Q, Zeng G, Dun Z, Qin A, Fontaine RE. Efficiency of quar-
lic health interventions in terms of cases detected, cases           antine during an epidemic of severe acute respiratory syndrome in
prevented, costs, and alleviating public concerns; identify-         Beijing, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:1037–40.
ing ways to make quarantines and other restrictions more         12. Blendon RJ, Benson JM, DesRoches CM, Raleigh E, Taylor-Clark K.
                                                                     The public’s reaction to severe acute respiratory syndrome in Toronto
focused and less burdensome for persons and societies;               and the United States. Clin Infect Dis. 2004;38:925–31.
assessment of how “leaky” restrictions can be before they        13. Hawryluck L, Gold WL, Robinson S, Pogorski S, Galea S, Styra R,
become ineffective; and developing rapid diagnostic tests.           et al. SARS control and psychological effects of quarantine, Toronto,
Limitations of the information include that it was collect-          Canada. Emerg Infect Dis. 2004;7:1206–12.
                                                                 14. Kaydos-Daniels SC, Olowokure B, Chang HJ, Barwick RS, Deng JF,
ed retrospectively, and in some studies, laboratory testing          Lee ML, et al. Body temperature monitoring and SARS fever hotline,
to confirm SARS-CoV infection was not performed. In the              Taiwan. Emerg Infect Dis. 2004;10:373–6.
event of future outbreaks, these issues will need to be stud-    15. Wu J, Xu F, Zhou W, Feikin DR, Lin CY, He X, et al. Risk factors for
ied prospectively so that decisions can be based on the best         SARS among persons without known contact with SARS patients,
                                                                     Beijing, China. Emerg Infect Dis. 2004;10:210–6.
scientific information.                                          16. Lau JTF, Tsui H, Lau M, Yang X. SARS transmission, risk factors,
                                                                     and prevention in Hong Kong. Emerg Infect Dis. 2004;10:587–92.
                                                                 17. Yu ITS, Li Y, Wong TW, Tam W, Chan AT, Lee JHW, et al. Evidence
     Dr. Bell is a senior medical officer in the Office of the       of airborne transmission of the severe acute respiratory syndrome
Director, National Center for Infectious Diseases, Centers for       virus. N Engl J Med. 2004;350:1731–9.
                        Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 11, November 2004                             1905
POLICY REVIEW
18. Update 11—WHO recommends new measures to prevent travel-                 25. Kenyon TA, Valway SE, Ihle WW, Onorato IM, Castro KG.
    related spread of SARS. Geneva. [cited 2003 Mar 27]. Available from          Transmission of multiudrug-resistant Mycobacterium tuberculosis
    http://www.who.int/csr/sars/archive/2003_03_27/en/                           during a long airplane flight. N Engl J Med. 1996;334:933–8.
19. Olsen SJ, Chang HL, Cheung TYY, Tang AFY, Fisk TL, Ooi SPL, et           26. World Health Organization. China’s latest SARS outbreak has been
    al. Transmission of the severe acute respiratory syndrome on aircraft.       contained, but biosafety concerns remain—update 7. [cited 2004 May
    N Engl J Med. 2003;349:2416–22.                                              18]. http://www.who.int/csr/don/2004_05_18a/en/
20. Desenclos JC, Van der Werf S, Bonmarin I, Levy-Bruhl D,                  27. World Health Organization. WHO consultation on priority public
    Yazdanpanah Y, Hoen B, et al. Introduction of SARS in France,                health interventions before and during an influenza pandemic.
    March–April, 2003. Emerg Infect Dis. 2004;10:195–200.                        Geneva. [cited 2004 Mar 16–18]. Available from
21. Wilder-Smith A, Paton NI, Goh KT. Low risk of transmission of                http://www.who.int/csr/disease/avian_influenza/consultation/en/
    severe acute respiratory syndrome on airplanes: the Singapore expe-      28. World Health Organization Scientific Research Advisory Committee
    rience. Trop Med Int Health. 2003;8:1035–7.                                  on Severe Acute Respiratory Syndrome (SARS). Report of the first
22. Breugelmans JG, Zucs P, Porten K, Broll S, Niedrig M, Ammon A, et            meeting,      Geneva,      Switzerland,     20–21     Oct     2003.
    al. SARS transmission and commercial aircraft. Emerg Infect Dis.             WHO/CDS/CSR/GAR/2004.16. [cited 2004 Sep 20]. Available from
    2004;10:1502–3.                                                              http://www.who.int/csr/resources/publications/WHO_CDS_CSR_G
23. Flint J, Burton S, Macey JF, Deeks SL, Tam TWS, King A, et al.               AR_2004_16/en/
    Assessment of in-flight transmission of SARS-results of contact trac-
    ing, Canada. Can Commun Dis Rep. 2003;29:105–10.                         Address for correspondence: David M. Bell, Office of the Director,
24. Moser MR, Bender TR, Margolis HS, Noble GR, Kendal AP, Ritter
                                                                             National Center for Infectious Diseases, Centers for Disease Control and
    G. An outbreak of influenza aboard a commercial airliner. Am J
    Epidemiol. 1979;110:1–6.                                                 Prevention, 1600 Clifton Road N.E., Mailstop C12, Atlanta, GA 30333,
                                                                             USA; fax: 404-639-4197; email: dbell@cdc.gov
1906 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 10, No. 11, November 2004